The pathology report

An accurate pathological assessment of core biopsies or resection specimens provides important information on the major features of breast cancer, such as tumor type, size, biological characteristics, lymph node status, stage, and extent of residual disease in case of neoadjuvant chemotherapy, and is crucial for ensuring an appropriate patient management. In the era of molecular medicine and tailored therapies, the pathologic assessment of primary tumor still represents an essential guide for oncologists and surgeons to inform the choice of the best treatment options available for individual patients. Therefore, the management of patients with breast cancer detected through imaging or symptomatic presentation depends heavily on the quality of the pathology service.